Significant advances have been made for treatment of acute ischemic stroke (AIS) such
as thrombolysis and thrombectomy. By contrast, there is yet time before daybreak in
the acute management of intracerebral hemorrhage (ICH). In the Japan Stroke Databank,
the rate of death or disability in ICH patients has increased, but not in AIS patients
for these 10 years (Sato S et al, 2017). Although many therapeutic options, including
surgical evacuation, are described for acute ICH patients, nothing has yet been proven
in large-scale randomized clinical trials (RCTs).
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of the Neurological SciencesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
